Testing Promising Behavioral Economic Interventions to Promote Enrollment Diversity in Cardiovascular Cohort Studies
BETTER P2
1 other identifier
interventional
26,242
1 country
1
Brief Summary
Problem. Randomized clinical trials (RCTs) are the best way to determine if interventions are safe and effective. Usually only a small number of eligible patients enroll. This is because trials require people to consent to be enrolled and randomized. Black and Hispanic people are more likely to develop heart disease. They are also more likely to have risk factors for heart disease that are not controlled. Yet they are very under-represented in heart disease trials. This raises concerns about if trial results can be applied to the general population. Trial sponsors are required to enroll patients that reflect the racial and ethnic diversity of real-world people. Black and Hispanic people continue to enroll in trials at a lower rate. The goal of this study is to conduct a series of small randomized trials to test recruitment strategies to increase how many Black and Hispanic people enroll in heart disease clinical trials without diminishing trust. The investigators will test different recruitment strategies for participant enrollment in a few different areas. They will study the method of outreach, the way messages are framed, defaults, and enrollment incentives. They will run smaller recruitment strategy trials within larger parent trials (e.g. Penn Medicine Biobank cohort study). They will run a small recruitment strategy trial to test each approach and then include what they learned in the next small trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable cardiovascular-diseases
Started Oct 2023
Shorter than P25 for not_applicable cardiovascular-diseases
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2023
CompletedFirst Posted
Study publicly available on registry
April 25, 2023
CompletedStudy Start
First participant enrolled
October 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedJanuary 24, 2025
January 1, 2025
1.1 years
March 23, 2023
January 21, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Enrollment fraction of Black + Hispanic patients
The number of Black and Hispanic patients who enroll in the cohort study, divided by the total number of Black and Hispanic patients attempted to be contacted for consideration of enrollment
three weeks after all attempts have been made to contact is made
Secondary Outcomes (6)
Enrollment fraction of Black patients
three weeks after all attempts have been made to contact is made
Enrollment fraction of Hispanic patients
three weeks after all attempts have been made to contact is made
Enrollment fraction by Area Deprivation Index (ADI) quartile
three weeks after all attempts have been made to contact is made
Overall enrollment fraction
three weeks after all attempts have been made to contact is made
Participation-to-prevalence ratio (PPR) for Black and Hispanic) patients
three weeks after all attempts have been made to contact is made
- +1 more secondary outcomes
Study Arms (13)
RCT #1, Arm #1: Contact Method, Text Only
ACTIVE COMPARATORPotential participants in the parent trial will be randomized to receive a message via text message. This message will invite them to participate in the parent trial.
RCT #1, Arm #2: Contact Method, Email Only
ACTIVE COMPARATORPotential participants in the parent trial will be randomized to receive a message via email. This message will invite them to participate in the parent trial.
RCT #1, Arm #3: Contact Method, Email+Text
ACTIVE COMPARATORPotential participants in the parent trial will be randomized to receive a message via email and text message. This message will invite them to participate in the parent trial.
RCT #2, Arm #1: Source of Contact, Personal Clinic
ACTIVE COMPARATORPotential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The sender of the message will be the person's personal clinic.
RCT #2, Arm #2: Source of Contact, Research Team
ACTIVE COMPARATORPotential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The sender of the message will be the research team.
RCT #3, Arm #1: Framing Method, Appeal to Altruism
ACTIVE COMPARATORPotential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will appeal to the person's altruism, for example: "Research studies like this one often do not include enough Black individuals. If Black people are not included in research like this, then doctors have less information about how cardiovascular disease might affect them and how new treatments could be used to improve their health. Your participation in this research can help doctors better understand how to treat members of your community in the future."
RCT #3, Arm #2: Framing Method, Social Proof
ACTIVE COMPARATORPotential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will include language about social proof, i.e. information about participation of individuals similar to the person being contacted. For example, the message will include language such as: "Clinical research studies and the development of effective new medications would not have been possible without the participation of thousands of people like you".
RCT #3, Arm #3: Framing Method, No Appeal to Altruism, No Social Proof
NO INTERVENTIONPotential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will include no language about appeal to altruism or social proof.
RCT #4, Arm #1: Incentive Structure, No Incentive
NO INTERVENTIONPotential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will have no language about incentives.
RCT #4, Arm #2: Incentive Structure, Guarantee Only
ACTIVE COMPARATORPotential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will state that, if the person decides to participate, they will receive $25.
RCT #4, Arm #3: Incentive Structure, Guarantee + Small Lottery
ACTIVE COMPARATORPotential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will state that, if the person decides to participate, they will receive $15 and have a 1 in 20 chance to receive $200.
RCT #4, Arm #4: Incentive Structure, Mid Lottery Only
ACTIVE COMPARATORPotential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will state that, if the person decides to participate, they will have a 1 in 20 chance to receive $500.
RCT #5, Arm #5: Incentive Structure, Large Lottery Only
ACTIVE COMPARATORPotential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will state that, if the person decides to participate, they will have a 1 in 100 chance to receive $2500.
Interventions
Behavioral Intervention studied here is the method of contact (text vs. email vs. email+text).
Behavioral Intervention studied here is source of contact (personal clinic vs. research team)
Behavioral Intervention studied here is the framing methods "appeal to altruism" and "social proof"
Behavioral Interventions studied here are guaranteed vs. lottery incentives
Eligibility Criteria
You may qualify if:
- must have active medical records in site's electronic medical record system.
You may not qualify if:
- an electronic portal account (e.g. MyPennMedicine)
- have previously been contacted to enroll in the parent trial (e.g. Penn Medicine Biobank)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pennsylvanialead
- American Heart Associationcollaborator
- Emory Universitycollaborator
Study Sites (1)
Penn Medicine
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Patients, investigators, and outcomes assessors will all be blinded to who arm each patient is enrolled into.
- Purpose
- OTHER
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 23, 2023
First Posted
April 25, 2023
Study Start
October 30, 2023
Primary Completion
December 1, 2024
Study Completion
December 1, 2024
Last Updated
January 24, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share